Skip to main content
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. — Investor Relations & Filings

Ticker · LRMR ISIN · US98885E1038 LEI · 529900NCBZHTTJV6HX73 US Professional, scientific and technical activities
Open in API
Filings indexed 666 across all filing types
Latest filing 2018-08-02 Board/Management Inform…
Country US United States of America
Listing US LRMR

About Larimar Therapeutics, Inc.

https://larimartx.com/

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company utilizes a proprietary intracellular delivery platform to design fusion proteins that deliver therapeutic molecules to targets within cells. Its lead product candidate, nomlabofusp (formerly CTI-1601), is a recombinant fusion protein being evaluated in a Phase 2 clinical program for the treatment of Friedreich's ataxia, a rare and progressive genetic disease. Larimar Therapeutics plans to leverage its platform to develop additional therapies for other rare diseases characterized by deficiencies in intracellular proteins.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The key content is the departure of a director/officer (Thomas E. Hughes, Ph.D.) from his roles as President, Chief Scientific Officer, and Director. The document includes details about the resignation and a press release attached as an exhibit. There is no financial data or report content, only an announcement of management changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 3723 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2018-08-02 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-07-09 English
4
Director's Dealing
2018-07-02 English
FORM 4 SUBMISSION
Director's Dealing
2018-06-29 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement related to a public offering of common stock, including underwriting details and pricing. It also references press releases about the offering. There are no financial statements or detailed financial results presented, only an announcement of a financing event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length and content confirm it is not a brief announcement or a certification, but a substantive filing about a financing transaction.
2018-06-28 English
424B5
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a public offering of common stock. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and other disclosures typical of a securities offering document. It is not a financial report, earnings release, management discussion, or any other type of corporate filing related to financial results or governance. The presence of terms like 'prospectus supplement', 'common stock offering', 'underwriting discounts', and references to SEC registration and securities laws clearly identify this as a capital raising document. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual offering document, not just an announcement or a brief summary.
2018-06-28 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.